Lionel L. Nowell III
Known title: DirectorCIK: 0001180436
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Textron Q3 2026 Earnings Preview and Industry News. Investors are focusing on Textron's upcoming Q3 2026 earnings report, which is a key upcoming event for the company. Recent news also highlights broader defense sector developments, including a major amphibious vehicle deal for a competitor and new Pentagon drone initiatives. These industry updates provide context for Textron's position in the aerospace and defense market ahead of its financial results.
Transaction History
| ECL | ▲ Buy | Grant | 130 | $0 | 6/30/2026 | View on chart |
| TXT | ▲ Buy | Grant | 2,061 | $0 | 4/29/2026 | View on chart |
| ECL | ▲ Buy | Grant | 138 | $0 | 3/31/2026 | View on chart |
| ECL | ▲ Buy | Grant | 128 | $0 | 12/31/2025 | View on chart |
| ECL | ▲ Buy | Grant | 123 | $0 | 9/30/2025 | View on chart |
| ECL | ▲ Buy | Grant | 126 | $0 | 6/30/2025 | View on chart |
| TXT | ▲ Buy | Grant | 2,794 | $0 | 4/23/2025 | View on chart |
| ECL | ▲ Buy | Grant | 134 | $0 | 3/31/2025 | View on chart |
| ECL | ▲ Buy | Grant | 144 | $0 | 12/31/2024 | View on chart |
| ECL | ▲ Buy | Grant | 133 | $0 | 9/30/2024 | View on chart |
| ECL | ▲ Buy | Grant | 141 | $0 | 6/30/2024 | View on chart |
| TXT | ▲ Buy | Grant | 1,756 | $0 | 4/24/2024 | View on chart |
| ECL | ▲ Buy | Grant | 146 | $0 | 3/31/2024 | View on chart |
| ECL | ▲ Buy | Grant | 157 | $0 | 12/31/2023 | View on chart |
| ECL | ▲ Buy | Grant | 184 | $0 | 9/30/2023 | View on chart |
| ECL | ▲ Buy | Grant | 168 | $0 | 6/30/2023 | View on chart |
| TXT | ▲ Buy | Grant | 2,517 | $0 | 4/26/2023 | View on chart |
| ECL | ▲ Buy | Grant | 190 | $0 | 3/31/2023 | View on chart |
| ECL | ▲ Buy | Grant | 215 | $0 | 12/31/2022 | View on chart |
| ECL | ▲ Buy | Grant | 214 | $0 | 9/30/2022 | View on chart |
| ECL | ▲ Buy | Grant | 205 | $0 | 6/30/2022 | View on chart |
| TXT | ▲ Buy | Grant | 2,174 | $0 | 4/27/2022 | View on chart |
| ECL | ▲ Buy | Grant | 175 | $0 | 3/31/2022 | View on chart |
| ECL | ▲ Buy | Grant | 128 | $30K | 12/31/2021 | View on chart |
| ECL | ▲ Buy | Grant | 123 | $0 | 12/31/2021 | View on chart |
| ECL | ▲ Buy | Grant | 136 | $0 | 9/30/2021 | View on chart |
| ECL | ▲ Buy | Grant | 142 | $30K | 9/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
RBC and Citi highlight Ecolab's pricing power and specialty chemical strength
Recent analyst notes from RBC Capital Markets and Citi have focused on Ecolab's ability to maintain pricing and organic growth. These firms view the company as a defensive option that may benefit from a weaker dollar. The positive sentiment aligns with the stock trading near its 52-week high, reflecting strong investor interest in its stable earnings profile.
RBC and Citi highlight Ecolab's pricing power and specialty chemical strength. Recent analyst notes from RBC Capital Markets and Citi have focused on Ecolab's ability to maintain pricing and organic growth. These firms view the company as a defensive option that may benefit from a weaker dollar. The positive sentiment aligns with the stock trading near its 52-week high, reflecting strong investor interest in its stable earnings profile.